Your browser doesn't support javascript.
loading
CRISPR-Based Tools in Immunity.
Simeonov, Dimitre R; Marson, Alexander.
Affiliation
  • Simeonov DR; Biomedical Sciences Graduate Program, University of California, San Francisco, California 94143, USA.
  • Marson A; Department of Microbiology and Immunology, University of California, San Francisco, California 94143, USA; email: alexander.marson@ucsf.edu.
Annu Rev Immunol ; 37: 571-597, 2019 04 26.
Article in En | MEDLINE | ID: mdl-30698999
ABSTRACT
CRISPR technology has opened a new era of genome interrogation and genome engineering. Discovered in bacteria, where it protects against bacteriophage by cleaving foreign nucleic acid sequences, the CRISPR system has been repurposed as an adaptable tool for genome editing and multiple other applications. CRISPR's ease of use, precision, and versatility have led to its widespread adoption, accelerating biomedical research and discovery in human cells and model organisms. Here we review CRISPR-based tools and discuss how they are being applied to decode the genetic circuits that control immune function in health and disease. Genetic variation in immune cells can affect autoimmune disease risk, infectious disease pathogenesis, and cancer immunotherapies. CRISPR provides unprecedented opportunities for functional mechanistic studies of coding and noncoding genome sequence function in immunity. Finally, we discuss the potential of CRISPR technology to engineer synthetic cellular immunotherapies for a wide range of human diseases.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Autoimmune Diseases / Cell- and Tissue-Based Therapy / Clustered Regularly Interspaced Short Palindromic Repeats / Infections / Neoplasms Limits: Animals / Humans Language: En Journal: Annu Rev Immunol Year: 2019 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Autoimmune Diseases / Cell- and Tissue-Based Therapy / Clustered Regularly Interspaced Short Palindromic Repeats / Infections / Neoplasms Limits: Animals / Humans Language: En Journal: Annu Rev Immunol Year: 2019 Type: Article Affiliation country: United States